W. G. Wierda Et Al. , "Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations," LEUKEMIA , vol.35, no.11, pp.3059-3072, 2021
Wierda, W. G. Et Al. 2021. Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations. LEUKEMIA , vol.35, no.11 , 3059-3072.
Wierda, W. G., Rawstron, A., Cymbalista, F., Badoux, X., Rossi, D., Brown, J. R., ... Egle, A.(2021). Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations. LEUKEMIA , vol.35, no.11, 3059-3072.
Wierda, William Et Al. "Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations," LEUKEMIA , vol.35, no.11, 3059-3072, 2021
Wierda, William G. Et Al. "Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations." LEUKEMIA , vol.35, no.11, pp.3059-3072, 2021
Wierda, W. G. Et Al. (2021) . "Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations." LEUKEMIA , vol.35, no.11, pp.3059-3072.
@article{article, author={William G. Wierda Et Al. }, title={Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations}, journal={LEUKEMIA}, year=2021, pages={3059-3072} }